Viewing Study NCT02772627


Ignite Creation Date: 2025-12-25 @ 5:11 AM
Ignite Modification Date: 2026-01-03 @ 10:37 PM
Study NCT ID: NCT02772627
Status: COMPLETED
Last Update Posted: 2016-05-13
First Post: 2016-05-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Investigate the Tolerability, Steady-state Pharmacokinetics and Erythrocyte COMT Inhibition of BIA 3-202
Sponsor: Bial - Portela C S.A.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Parkinson's Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Parkinson's disease, Nebicapone View